Emerald Cloud Lab
PrivateLast Round
Series B
Extension
Apr 29, 2024
Total Funding Raised
$181.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Emerald Cloud Lab is a biotechnology company that provides a remote-controlled, highly automated life science laboratory platform for researchers to design, execute, and analyze experiments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Cloud Infrastructure, Biotech Equipment, Workflow Automation
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emerald Cloud Lab Comparables
Compare Emerald Cloud Lab with similar companies based on industry and business-model similarity.
Emerald Cloud Lab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 29, 2024 | ||||
| Series C | Jun 3, 2022 | ||||
| Debt | Jul 13, 2021 | ||||
| Series B | Sep 24, 2019 | ||||
| Series C | Jun 1, 2015 | ||||
Series B | Jul 1, 2014 |
Key People
Founding team and executive leadership
Emerald Cloud Lab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B |
| Merck Global Health Innovation Fund | Series C |
| Neoteny | Series C |
| Founders Fund | Series C, Seed, Series A, Series B |
| Bezos Expeditions | Series B |
| GigaFund | Series C |
| Sound Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 46% MoM.
- Jun 17, 2026
Monthly visitors increased 31% MoM.
Emerald Cloud Lab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Emerald Cloud Lab's valuation, stock price, and market status.
Is Emerald Therapeutics a public or private company?
Emerald Therapeutics is a private company.
What is the current stock price of Emerald Therapeutics?
Emerald Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Emerald Therapeutics worth (valuation)?
Valuation information for Emerald Therapeutics is not publicly available.
Can I buy Emerald Therapeutics stock?
Emerald Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Emerald Therapeutics's last funding round?
Emerald Therapeutics's most recent funding round was Series C on June 3, 2022.
Who are the main investors in Emerald Therapeutics?
Key investors in Emerald Therapeutics include Founders Fund, Trinity Capital, Schooner Capital.
Will Emerald Therapeutics IPO soon?
No public IPO plans have been announced for Emerald Therapeutics.
How can I track Emerald Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Emerald Therapeutics's secondary market activity and sign up for updates.